Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA 403 Forbidden error page now appears, replacing the full study record and preventing viewing the trial details. The error page shows a minimal header with 403 Forbidden, indicating an access issue rather than content.SummaryDifference19%

- Check55 days agoChange DetectedThe page's revision was updated from v3.6.5 to v3.6.6, indicating a minor update to the record rather than changes to the study details.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a newer release of the study record's metadata.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a small backend/template update to the page.SummaryDifference0.0%

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.